275 related articles for article (PubMed ID: 21858450)
1. Roles for CCN2 in normal physiological processes.
Hall-Glenn F; Lyons KM
Cell Mol Life Sci; 2011 Oct; 68(19):3209-17. PubMed ID: 21858450
[TBL] [Abstract][Full Text] [Related]
2. Studying the CCN Proteins in Fibrosis.
Hutchenreuther J; Leask A; Thompson K
Methods Mol Biol; 2017; 1489():423-429. PubMed ID: 27734394
[TBL] [Abstract][Full Text] [Related]
3. CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis.
Hall-Glenn F; De Young RA; Huang BL; van Handel B; Hofmann JJ; Chen TT; Choi A; Ong JR; Benya PD; Mikkola H; Iruela-Arispe ML; Lyons KM
PLoS One; 2012; 7(2):e30562. PubMed ID: 22363445
[TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation.
Rayego-Mateos S; Morgado-Pascual JL; Rodrigues-Diez RR; Rodrigues-Diez R; Falke LL; Mezzano S; Ortiz A; Egido J; Goldschmeding R; Ruiz-Ortega M
J Pathol; 2018 Feb; 244(2):227-241. PubMed ID: 29160908
[TBL] [Abstract][Full Text] [Related]
5. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis.
Yoon PO; Lee MA; Cha H; Jeong MH; Kim J; Jang SP; Choi BY; Jeong D; Yang DK; Hajjar RJ; Park WJ
J Mol Cell Cardiol; 2010 Aug; 49(2):294-303. PubMed ID: 20430035
[TBL] [Abstract][Full Text] [Related]
6. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
7. Impaired intervertebral disc development and premature disc degeneration in mice with notochord-specific deletion of CCN2.
Bedore J; Sha W; McCann MR; Liu S; Leask A; Séguin CA
Arthritis Rheum; 2013 Oct; 65(10):2634-44. PubMed ID: 23839921
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor/CCN2-null mouse embryonic fibroblasts retain intact transforming growth factor-beta responsiveness.
Mori Y; Hinchcliff M; Wu M; Warner-Blankenship M; M Lyons K; Varga J
Exp Cell Res; 2008 Mar; 314(5):1094-104. PubMed ID: 18201696
[TBL] [Abstract][Full Text] [Related]
9. Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension.
Tam AYY; Horwell AL; Trinder SL; Khan K; Xu S; Ong V; Denton CP; Norman JT; Holmes AM; Bou-Gharios G; Abraham DJ
Int J Biochem Cell Biol; 2021 May; 134():105961. PubMed ID: 33662577
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions.
Kubota S; Takigawa M
Clin Sci (Lond); 2015 Feb; 128(3):181-96. PubMed ID: 25294165
[TBL] [Abstract][Full Text] [Related]
11. CCN2 participates in overload-induced skeletal muscle hypertrophy.
Petrosino JM; Longenecker JZ; Angell CD; Hinger SA; Martens CR; Accornero F
Matrix Biol; 2022 Feb; 106():1-11. PubMed ID: 35045313
[TBL] [Abstract][Full Text] [Related]
12. The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.
Arnott JA; Lambi AG; Mundy C; Hendesi H; Pixley RA; Owen TA; Safadi FF; Popoff SN
Crit Rev Eukaryot Gene Expr; 2011; 21(1):43-69. PubMed ID: 21967332
[TBL] [Abstract][Full Text] [Related]
13. Regulation of hepatic stellate cells by connective tissue growth factor.
Huang G; Brigstock DR
Front Biosci (Landmark Ed); 2012 Jun; 17(7):2495-507. PubMed ID: 22652794
[TBL] [Abstract][Full Text] [Related]
14. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program.
Nakerakanti SS; Kapanadze B; Yamasaki M; Markiewicz M; Trojanowska M
J Biol Chem; 2006 Sep; 281(35):25259-69. PubMed ID: 16829517
[TBL] [Abstract][Full Text] [Related]
15. CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure.
Tsoutsman T; Wang X; Garchow K; Riser B; Twigg S; Semsarian C
J Mol Cell Cardiol; 2013 Sep; 62():164-78. PubMed ID: 23756156
[TBL] [Abstract][Full Text] [Related]
16. Denervation-induced skeletal muscle fibrosis is mediated by CTGF/CCN2 independently of TGF-β.
Rebolledo DL; González D; Faundez-Contreras J; Contreras O; Vio CP; Murphy-Ullrich JE; Lipson KE; Brandan E
Matrix Biol; 2019 Sep; 82():20-37. PubMed ID: 30716392
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor-(CTGF, CCN2)--a marker, mediator and therapeutic target for renal fibrosis.
Phanish MK; Winn SK; Dockrell ME
Nephron Exp Nephrol; 2010; 114(3):e83-92. PubMed ID: 19955828
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation.
Kaasbøll OJ; Gadicherla AK; Wang JH; Monsen VT; Hagelin EMV; Dong MQ; Attramadal H
J Biol Chem; 2018 Nov; 293(46):17953-17970. PubMed ID: 30262666
[TBL] [Abstract][Full Text] [Related]
19. CCN2: a novel, specific and valid target for anti-fibrotic drug intervention.
Leask A
Expert Opin Ther Targets; 2013 Sep; 17(9):1067-71. PubMed ID: 23848501
[TBL] [Abstract][Full Text] [Related]
20. Activation of cancer-associated fibroblasts is required for tumor neovascularization in a murine model of melanoma.
Hutchenreuther J; Vincent K; Norley C; Racanelli M; Gruber SB; Johnson TM; Fullen DR; Raskin L; Perbal B; Holdsworth DW; Postovit LM; Leask A
Matrix Biol; 2018 Dec; 74():52-61. PubMed ID: 29885461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
